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Improving Current Glycated Hemoglobin Prediction in 




Predicting the risk of glycated hemoglobin (HbA1c) elevation can help identify patients 
with the potential for developing serious chronic health problems such as diabetes. Early 
preventive interventions based upon advanced predictive models using electronic health 
records (EHR) data for identifying such patients can ultimately help provide better health 
outcomes.  
Objective: 
Our study investigates the performance of predictive models to forecast HbA1c elevation 
levels by employing several machine learning models. We also investigate utilizing the 
patient's EHR longitudinal data in the performance of the predictive models. Explainable 
methods have been employed to interpret the decisions made by the blackbox models. 
Methods:  
This study employed Multiple Logistic Regression, Random Forest, Support Vector 
Machine and Logistic Regression models, as well as a deep learning model (Multi-layer 
perceptron) to classify patients with normal (<5.7%) and elevated (≥5.7%) levels of 
HbA1c. We also integrated current visit data with historical (longitudinal) data from 
previous visits. Explainable machine learning methods were used to interrogate the 
models and provide an understanding of the reasons behind the decisions made by the 
models. All models were trained and tested using a large dataset from Saudi Arabia with 
18,844 unique patient records. 
Results:  
The machine learning models achieved promising results for predicting current HbA1c 
elevation risk. When employed with longitudinal data, the machine learning models 
outperformed the Multiple Logistic Regression model employed in the comparative 
study. The multi-layer perceptron model achieved an accuracy of 83.22% for the AUC-
ROC when used with historical data. All models showed close level of agreement on the 
contribution of random blood sugar and age variables with and without longitudinal data. 
 
Conclusions:  
This study shows that machine learning models can provide promising results for the task 
of predicting current HbA1c levels (≥5.7% or less). Utilizing the patient's longitudinal 
data improved the performance and affected the relative importance for the predictors 
used. The models showed results that are consistent with comparable studies.  
 
Keywords: Glycated Hemoglobin HbA1c; Prediction; Machine Learning; Deep 
Learning; Neural Network; Multi-Layer Perceptron; Electronic Health Records; Time-




The level of glycated hemoglobin (HbA1c) is used to measure the average glucose 
concentration in red blood cells [1, 2]. Unlike other glucose blood tests such as Random 
Blood Sugar (RBS) and Fasting Blood Sugar (FBS), HbA1c provides a long-term 
measure of a patient’s blood glucose levels [3]. The HbA1c test can therefore provide 
physicians with a reliable means of monitoring a patient’s hyperglycemia without 
requiring the patient to undertake overnight fasting prior to being tested. 
 
A concentration of 6.5% for the Glycated Haemoglobin (HbA1c) in patient blood is 
considered as a cut-off point for the diagnosis of diabetes [4]. However, patients with a 
concentration of less than 6.5% are not completely excluded from a diabetes diagnosis as 
the range of elevation levels (5.7%≤ HbA1c <6.5%) can indicate the future onset of 
diabetes. Therefore, HbA1c can act as an early predictor for the potential development of 
Type-2 Diabetes Mellitus (T2DM) [2]. Ackermann et al suggested using the HbA1c test 
as a measure for identifying those adults who are at a greater risk of developing T2DM in 
the future  [3]. 
 
Research has shown that reducing HbA1c levels can significantly reduce the possibility 
of developing serious complications. Hence, close monitoring of HbA1c levels is 
recommended for all diabetic patients and also for those with the potential for developing 
diabetes [5]. It is also suggested that diabetic and non-diabetic patients with raised 
HbA1c levels should be clinically checked and monitored as a preventive intervention to 
avoid developing T2DM [6].  
 
Currently, the clinical data collected from patient visits consists of a set of readings for 
vital signs and lab tests, diagnosis, physician’s notes, and treatments that are stored in 
Electronic Health Records (EHR). These are collected on an irregular basis, according to 
clinical needs, and stored with an associated timestamp.  
 
In recent years, machine learning models have shown powerful capabilities for analyzing 
and understanding complex data across a wide variety of applications. Our research 
question for this study is: “Can HbA1c prediction be improved by using machine learning 
and utilizing longitudinal data that are normally available in EHR systems?”.  
 
This paper reports an investigation into the performance of machine learning models to 
predict current HbA1c levels as a binary classification problem using the EHR data. Non-
diabetic patients with an HbA1c level of 5.7% or more are considered to have an elevated 
HbA1c, while those with lower levels than that are considered normal. The models 
combine current visit data with extra features (independent variables) extracted from 
previous visits by patients. We used explainable methods to rank the features in order of 
their importance to the decision made by each of the models. To the best of our knowledge, 
this work is the first to employ machine learning models that use longitudinal data from 
EHR systems for the purpose of HbA1c elevation risk prediction. This work is also the 
first to utilize explainable machine learning techniques to explain the classification 
decisions made by the black box models (SVM and MLP) in predicting HbA1c elevation 





EHR data has been intensively investigated for a variety of medical decision support 
tasks [7]. These tasks include the analysis of complex patterns and prediction of major 
medical events (for example, diagnostic imaging and genes interactions) [8, 9]. Several 
studies have demonstrated the successful employment of EHR data with prediction 
models [10]. For instance, machine learning, has been intensively used in diagnosing 
diabetes, and discovering its related patterns, using EHR data [11-15]. However, we are 
not aware of any studies that have explored machine learning models for the prediction of 
current elevated HbA1c levels using EHR data from a non-diabetic population, as well as 
the impact of patient longitudinal data on the effectiveness of such predictive machine 
learning models. 
 
Several studies have investigated the association between HbA1c levels and clinical 
variables using statistical models [16] [17]. A study by Rose et al [18] discussed the 
correlation between RBS and HbA1c levels. Stanley et al [19] used a linear regression 
model for imputation of missing HbA1c data. Their model calculates HbA1c levels for 
patient records with missing HbA1c values as continuous and categorical values and uses 
4 predictors extracted from an EHR system: RBS, FBS, along with age and gender, as 
predictors to calculate the level of HbA1c for a diabetic population. Simone et al [20] 
used linear regression models to predict HbA1c levels after 6 years for non-diabetic 
patients using different populations. 
 
A study by Wells et al [21] in 2018 was the first to focus on predicting current HbA1c 
elevation levels for non-diabetic patients using an EHR dataset. Multiple Logistic 
Regression (MLR) was employed to calculate the probability of a patient having an 
elevated HbA1c level (≥5.7%). The dataset was extracted from an EHR system used in 
the USA. The authors used 8 independent variables fitted to the model using Restricted 
Cubic Splines (RCS) with 3-knots to formulate the final equation. The performance of the 
MLR model was compared to that of the models used by Baan et al [22] and Griffin et al 
[23]. However, the models by Baan and Griffin aimed at predicting the onset of patients’ 
diabetes rather than predicting HbA1c levels for non-diabetic patients. In addition, the 
experimental dataset used by Wells et al to train and test their model was imbalanced 
with 74% of the samples having normal HbA1c levels (<5.7%) and only 26% of the 
samples having elevated HbA1c levels (≥5.7%). 
 
We have performed a differentiated replication of the study by Wells et al [21] using the 
more balanced KAIMRC dataset [24]. While the significant variables identified in our 
replication were in general agreement with those of the original study, there were some 
differences in the ranking of importance for these, suggesting that such models do need to 







To study the impact of employing advanced predictive models with EHR data to predict 
current HbA1c levels, we employed the Multiple Logistic Regression (MLR), Random 
Forest (RF), Support Vector Machine (SVM) and Logistic Regression (LR) models; as 
well as a deep learning model, Multi-layer Perceptron (MLP) [25]. The problem was 
formulated into binary classification problem whereby the target variable, HbA1c level, 
was encoded with 1 when the level of HbA1c is 5.7% or more and with 0 otherwise. The 
results obtained from using these models were compared to those obtained from 
employing the model used by Wells et al with the KAIMRC dataset (detailed in the 
Dataset subsection). The performance of the models was investigated using current visit 
data only and also with additional longitudinal data from current and previous visits. The 
performance of each model was evaluated using measures commonly employed in 
clinical applications. For the SVM and MLP models, the relative importance of the 
features was also calculated using explainable machine learning techniques.  
 
Using black box machine learning models in healthcare can have adverse effects on the 
trust and confidence placed in their outcomes; the risk of misclassification is potentially 
too high for clinicians to confidently use black box models for high risk healthcare 
decisions, and not being able to interpret a model’s decision exacerbates this problem 
[26]. Explainable methods for machine learning models allow interpretable outcomes that 
can expose the reasons behind the decision made by the model [27]. This transparency 
provides both health professionals and patients with the confidence and trust in the 
outcome of the models. The widely-used SHAP (SHapley Additive exPlanations) values 
[28] and LIME scores [29] techniques have therefore been employed to provide a degree 
of transparency to our deep learning model.  
 
SHAP values are derived from Shapley values used in game theory, and provide a 
method of calculating the contribution of each feature (variable) to the final prediction 
via the GradientSHAP approximation. This is achieved for each feature by comparing 
 the prediction the model makes when the feature is present with the prediction obtained 
when the feature takes some baseline value [28]. Consequently, the SHAP values for a 
given input ‘explain’ how each feature affects the output of the model when compared to 
the baseline (or ’default’) output of the model. We use SHAP values to interpret our 
black box models, as they can be efficiently calculated, and their use enables a global 
view of the model to be constructed through the computation of SHAP values from 
across the whole dataset. 
 
SHAP values are computed using the feature’s mean marginal contribution across 
different coalitions of all features. Shapley values themselves are computationally 
intensive to compute, and so approximation methods are commonly used when 
calculating the values. 
 
To ensure that the SHAP values we calculate are not too greatly affected by the 
approximation method used, we also compute the LIME [29] scores for the models, 
across the entire dataset. LIME tries to estimate locally faithful linear explanations (i.e. 
explanations that correspond to how the model behaves around the instance being 
explained) for any classifier. LIME achieves this by creating local linear classifiers that 
approximate the behavior of the original model in the vicinity of the data being 
explained. As linear models are inherently interpretable through their parameters, they 
can be used to generate explanations of the original model. Both SHAP and LIME have 
the advantage that they are model-agnostic techniques, and so we are able to apply both 





The data used in this study is taken from the King Abdullah International Research 
Center (KAIMRC) dataset. The data has been collected from King Abdulaziz Medical 
City located in the central and western regions of Saudi Arabia (KSA), which the World 
Health Organization (WHO) ranked as the second highest in the Middle East for 
prevalence of diabetes, and 17th in the world [30]. According to the International 
Diabetes Federation (IDF), the diabetes prevalence rate in Saudi Arabia is 18.3%. 
Therefore, the availability of the data from this population provides considerable 
opportunities for research into the early prediction of diabetes.  
 
The dataset contains a full history of patient details, vital signs, and lab test readings for 
each patient visit for the period from 2016 to the end of 2018. As the aim of this study is 
to identify non-diabetic patients that are at a high risk of HbA1c elevation, all patients 
previously diagnosed with hyperglycemia were eliminated from the experimental dataset. 
The remaining cohort formed our experimental dataset, and was categorized by using the 
American Diabetes Association’s (ADA) guidelines [31]. Patients with HbA1c readings 
of more than 5.7% are considered as being in the pre-diabetic range while those with less 
than 5.7% are considered to be in the normal range.  
 
Most medical datasets are imbalanced [32]  [33] [34]. Such imbalances occur when the 
proportion of one class of patients in the dataset is greater than its counterpart class [35] 
[36]. However, unusually, our experimental dataset is not imbalanced. Slightly over half 
of the patients in our experimental dataset (52.1%) were found to have elevated levels of 
HbA1c (≥5.7%) while 47.9% of patients had normal HbA1c levels (<5.7%). This can be 
ascribed to the high incidence of diabetes in the region from which the dataset was 
collected [37]. 
 
A detailed illustration of the patients’ class distribution (HbA1c levels) by age groups and 
gender is shown in Figure 1. This shows that as the age of patients increases, so  
the proportion of patients who have elevated HbA1c levels is steadily increasing. The 
dataset also exhibits a balanced gender distribution, with 49.4% of the patients being 
male and 50.6% female. However, the proportion of male patients with elevated levels of 
HbA1c (≥5.7%) is greater than for the female patients. Also, female patients with normal 
levels of HbA1c (<5.7%) made more visits than males. Table 1 shows the profile for the 





Figure 1. HbA1c Elevation levels distributed over age range and gender in the KAIMRC 
dataset (before sampling). 
 
 
Table 1.  Profile for the class distribution over gender. 
Characteristics HbA1c <5.7% HbA1c ≥5.7% 
    
Number of patients 
(Total:18,844) 
Total (%) 9,018 (47.9%) 9,826 (52.1%) 
Male% 41 .73% 56.42% 
Female% 58.27% 43.58% 
Total 79,607 77,993 
Number of visits (Total: 
157,600)  
Male% 39.72% 53.32% 




Feature Selection and Data Sampling 
 
Six main variables (features) were extracted from the KAIMRC EHR dataset to be used 
in this study. These features were selected firstly for their theoretical association with 
hyperglycemia and secondly for their availability in the KAIMRC dataset, and are: Age, 
Body Mass Index (BMI), Estimated Glomerular Filtration Rate (eGFR), Random Blood 
Sugar (RBS), Total cholesterol (CHOL) and non-high-density lipoprotein (non-HDL). 
For the lab codes of the features used, refer to Table 1 in Multimedia Appendix 1.  The 
descriptive statistics (using the data for the current visit only for unique patients), units, 
and P values for the selected features are presented in Table 2. 
 
Table 2.  Descriptive statistics of the selected features from the KAIMRC dataset. 
Feature Unit HbA1c 
<5.7% 
HbA1c ≥5.7% P Value 
     
Age mean (SD) Years 43.94 (16.38) 58.92 (15.12) <0.001 
BMI mean (SD) Kg/m2 29.11 (6.75) 30.90 (6.55) <0.001 
eGFR mean (SD) mL/min/1.73 m2  100.03 (29.22) 85.81 (28.239) <0.001 
RBS mean (SD) mmol/L 5.45 (1.26) 7.88 (4.19) <0.001 
Cholesterol mean (SD) mmol/L 4.65 (1.07) 4.42 (1.20) <0.001 
non-HDL mean (SD) mmol/L 3.45 (1.01) 3.37 (1.115) <0.001 
 
 
It is very common in clinical practice that physicians may require that some lab tests and 
vital signs be recorded frequently. In these cases, the average value of all readings taken 
on a given day (the basic time interval used for this study) was used. For inpatient visits, 
only data for the first day were considered and where there were missing values, the first 
available values from the visit were used.  
 
For the purpose of this study we aim at predicting the HbA1c levels (≥5.7%) for current 
(last) patient visits only. Unlike the sampling approach used by Wells et al, which was 
based on independent hospital visits for patients (including for the same patients), the 
sampling approach used in this study includes independent patients, to ensure only 
unseen patients data are used for testing the models.  Since we aim at identifying patients 
with elevated levels of HbA1c from non-diabetic population, patients previously 
diagnosed with diabetes were excluded. We also excluded non-adult patients and those 
with erroneous or missing values [24]. Figure 2 shows the details of the tasks performed 
to refine the sample selection. This resulted in a reduction in the size of the experimental 
dataset from 114,057 patients with 750,709 visits to 18,844 unique patients with 157,600 
visits. 
 
Figure 2. Details of the sampling approach performed on the KAIMRC dataset. 
 
 
The inputs (input features space) for the models used in this study were continuous 
values. Values for age, eGFR, RBS and CHOL features were directly available in the 
KAIMRC dataset. The values for the BMI and non-HDL variables were calculated from 
other available features using the formulae in Multimedia Appendix 2. 
 
Input Preparation for the Models 
 
The input structure for the deep learning model was organized as a matrix, based on 
current and previous time-stamped patient visits. It contained the current visit data 
concatenated with approximated values for the selected features from all previous visits, 
which we refer to as the “Approximated Time Series Data”. 
 
Each patient visit is described by the selected features, represented as 𝑥1,  𝑥2, ⋯ , 𝑥𝑛 





𝑣1 𝑥11 𝑥12 ⋯ 𝑥1𝑛
𝑣2 𝑥21 𝑥22 ⋯ 𝑥2𝑛
⋮ ⋮ ⋮ ⋯ ⋮
𝑣𝑠 𝑥𝑠1 𝑥𝑠2 ⋯ 𝑥𝑠𝑛
]   (Eq:1) 
 
Here 𝑥𝑖𝑗 is the feature value at a patient visit 𝑣𝑖 (0 < 𝑖 ≥ 𝑠, 0 < 𝑗 ≥ 𝑛); 𝑠 is the number 
of time series steps (the length of the input sequence); and 𝑛 is the number of features for 
each time step, which is set to 6 as explained earlier.  
 
If the number of visits (longitudinal time-series visits) for a patient is fewer than 𝑠, the 
input for this patient is padded out with the mean value of the available visits to 
compensate for the missing time-series data (Multimedia Appendix 3 shows an example 
of the padding approach used). Where the number of longitudinal visits for a patient is 
more than 𝑠, the Piece-wise Aggregation Approximation (PAA) technique [38] is applied 
to the data for these visits to take account of all data from patient visits.  
 
PAA transforms the longitudinal time-series data using 𝑠 as a number of sliding windows 
(or segments), into a reduced number of time steps data (approximated) employing the 
mean value of the series falling within that window (segment) [39]. We tested the models 
with several values for the size of the sliding window (𝑠), and 3 was shown to be the 
optimal value. The formula used to calculate the approximated time-series data is: 
 












, 𝑠 < 𝑟 − 1 
 
where ?̃?𝑖 represents the approximated value for 𝑥 and 𝑟 is the total number of visits for a 
patient. 𝑠 is the reduced number of time-series steps (Multimedia Appendix 4 shows an 
example of the PAA technique used). 
 
 
The approximated time-series data forming the output of the PAA is then concatenated 
with the current visit data to form the final input for the deep learning model. Since the 
MLR, RF, SVM and LR models are not capable of handling the multi-dimensional data 
(formed as matrices), for these the output of the PAA was re-organized into a single-
dimensional input by vectorizing the matrix used in equation (Eq1) as below: 
 
𝐼𝑛𝑝𝑢𝑡 = [𝑥11 𝑥12 𝑥13 ⋯ 𝑥𝑠𝑛]  (Eq:3) 
 
The last data pre-processing task before training the predictive models was data scaling. 
The experimental dataset was scaled using the normalization technique that re-scales the 
ranges of each of the features to be between 0 and 1 using minimum and maximum 
values of that feature. 
 
 
Predictive Models and Experimental Setups  
 
As a baseline comparison, we employed the Multiple Logistic Regression (MLR) model 
used by Wells et al, and compared the results from this with those from 4 commonly used 
machine learning models. 
 
The MLR model is used to create a mathematical equation that can best calculate the 
probability of a value by the assigning weights (coefficients) to the independent variables 
(features) based on their importance [40]. In this study we employed the same approach 
used by Wells et al by which the continuous features were fitted into the MLR model 
using Restricted Cubic Splines (RCS) technique with 3-knots. When using the 
longitudinal input, the variables that caused collinearity were excluded. 
 
Random Forest (RF) is an algorithm very commonly used for classification. It combines 
several decision trees that are generated during the training process. Each decision tree is 
trained using a random subset of the training dataset.  The final classification is then 
based on the majority voting results of all generated decision trees [41]. The quality 
function used in the employed RF model is Gini, with a value of 100 for the number of 
trees parameters. 
 
Logistic regression (LR) is commonly used to solve binary classification problems. It 
calculates the odds ratio of the variables, and is similar to multiple linear regression but 
uses a binomial distribution of the dependent variable (i.e. more than 1). Thus, it includes 
a logit function that handles different types of relationships between the dependent and 
independent variables [42] [43].  
 
Support Vector Machine (SVM) was introduced by Vapnik [44] in 1998. It can solve 
both classification and regression problems. It uses the training feature space to decide on 
the separation boundaries (hyperplane) that best divides the training dataset into regions, 
one for each class. The very close points to the hyperplanes are the support vectors. 
SVMs also use kernels to help enhance class separation by mapping the training features 
into a higher dimensional space with an increased number of dimensions [45] [44]. The 
kernel function used in SVM model employed is Radial Base Function (RBF) with a 
value of 1 for the cost parameter (C). 
 
Multi-layer perceptron (MLP), also known as a feed-forward neural network, is one of 
the most common deep learning approaches. MLP is mainly used to address supervised 
learning problems by learning the dependencies between the input layer (the features or 
variables) and output layer (the classification decision) using a fully connected hidden 
layer in-between. The layers, including hidden ones, contain a number of neurons that are 
connected to the neurons of the next and previous layers via weights and non-linear 
functions. MLP uses a backpropagation algorithm to update the weights and biases within 
the hidden layers to minimize the output error rate [46] [25]. 
 
To optimize the MLP model, fine tuning of the structure and hyperparameters has been 
performed, involving the number of hidden layers and neurons, activation functions, 
optimizers and loss functions. The optimized structure of the MLP model used in this 
study contained 3 hidden layers. The number of neurons in the hidden layers were 48, 48, 
and 24, respectively. The final layer (the output layer) contained 2 neurons for the final 
output of the model (𝑌1 for normal or 𝑌2 for elevated HbA1c). A relu activation function 
was used in the 3 hidden layers and a sigmoid in the output layer. The detailed structure 
of the MLP model is shown in Figure 3. The model was trained using an Adam optimizer 









Evaluation of Model Performance 
 
The models all employed the same data pre-processing, training, and testing techniques. 
The models were validated using the 10-fold cross-validation technique. The K-fold CV 
is one of the most commonly approximation approaches used  for validating the obtained 
results [47, 48]. For the MLP model, 100 epochs were used to train each fold.  
 
As our measure for evaluating and comparing the performance of the proposed models, 
we used the area under the receiver operating characteristic (AUC-ROC), which is equal 
to the concordance statistic [49]. We also report values for a set of measures that are 
commonly used in clinical applications: balanced accuracy (that calculates the recall 
average for each class), overall accuracy, F1-score, precision and precision-recall area 
under the curve (PR-AUC). 
 
To determine the importance that the black box models (SVM and MLP) place 
upon each variable, we first compute the SHAP values and LIME scores for all samples 






Table 3 shows the performance metrics obtained using the MLR, RF, SVM, LR and MLP 
models with and without the longitudinal data.  The results show that the models 
achieved competitive performance using the reported measures. The LR and MLP models 
trained with and without the longitudinal data achieved better performance with regards 
to the AUC-ROC measure than the MLR (statistical model employed by Wells et al), as 
well as the RF and SVM models. (More details about AUC-ROC and PR-AUC curve 
plots are presented in Multimedia Appendix 5.). The results also show that the SVM, LR 
and MLP models trained with and without the longitudinal data achieved better 
performance than the MLR and RF using the balanced accuracy measure. 
 
Table 3 also shows that all models, including the MLR, achieved better performance 
using all reported measures when they are trained with the features from patients’ 
longitudinal data. The MLP with longitudinal data slightly outperformed all other models 
with respect to the reported measures.  
 
 















MLRa No 81.38% (3.82) 72.74% (4.15) 73.59% (3.79) 74.91% (5.12) 73.20% (5.05) 82.14% (6.04) 
Yes 82.45% (4.09) 73.49% (4.19) 74.30% (4.02) 75.11% (6.00) 74.36% (5.26) 83.45% (6.29) 
RFb No 80.82% (1.14) 72.57% (1.17) 72.64% (1.14) 73.97% (1.04) 73.42% (1.84) 82.03% (1.35) 
Yes 82.38% (1.04) 73.86% (0.98) 73.91% (0.95) 75.07% (0.86) 74.81% (1.68) 84.06% (1.17) 
SVMc No 81.05% (1.04) 73.69% (1.35) 73.88% (1.33) 75.76% (1.18) 73.42% (1.90) 80.56% (1.48) 
Yes 82.04% (0.89) 74.25% (1.11) 74.40% (1.08) 76.08% (0.92) 74.20% (1.65) 83.16% (1.19) 
LRd No 81.51% (1.26) 73.18% (1.10) 73.17% (1.08) 73.96% (1.03) 74.88% (1.69) 82.49% (1.46) 
Yes 82.59% (1.04) 74.11% (1.15) 74.05% (1.13) 74.55% (0.98) 76.31% (1.72) 84.13% (1.04) 
MLPe No 82.07% (1.06) 73.61% (1.04) 73.83% (1.03) 75.87% (1.10) 73.07% (1.62) 83.42% (1.19) 
Yes 83.22% (0.92) 74.45% (1.18) 74.55% (1.18) 75.99% (1.95) 74.78% (2.07) 84.85% (0.78) 
aMLR: Multiple Logistic Regression.  
bRF: Random Forest.  
cSVM: Support Vector Machine.  
dLR: Logistic Regression.  
eMLP: Multi-Layer Perceptron.  
fSD: Standard deviation. 
 
 
Figure 4 summarizes the 10-folds performance achieved for the set of measures where 
the models were trained without longitudinal data, and Figure 5 shows the performance 
where they were trained with the longitudinal data. Both figures show a more consistent 
prediction trend for RF, LR, SVM as well as MLP with and without longitudinal data, as 
the measures for these models show a small variation between the folds. As shown in 
Figures 4 and 5, the SD values for MLR with and without longitudinal data are larger 
than for the rest of the models. This indicates that the machine learning models used can 
not only enhance the performance, but also improve the classification confidence for 
HbA1c prediction. 
 
Figure 4. Boxplots showing the detailed 10-folds performance of all models trained 









Table 4 shows the ranked order of importance of the set of predictors used for training the 
models. Further detail on the actual importance values for each model is provided in 
Multimedia Appendix 6. (Refer to Multimedia Appendix 7 for more details of the MLR 
and LR calculator.) Calculating the importance of the predictors for the MLP models 
using vectorized longitudinal data was not possible due to the collinearity caused by 
having multiple variables for BMI. The order of importance results obtained using the 
SHAP method for both the SVM and MLP are identical to those obtained using LIME, 









1st   2nd   3rd   4th   5th   6th   
MLR No Age  RBS  BMI CHOL  Non-HDL eGFR  
RF 
No Age  RBS  BMI eGFR  CHOL Non-HDL  
Yes RBS Age CHOL eGFR  Non-HDL  BMI 
LR 
No RBS  Age  Non-HDL  CHOL  BMI  eGFR  
Yes RBS Age Non-HDL  eGFR CHOL  BMI 
SVM (SHAP 
& LIME) 
No Age  RBS  BMI  Non-HDL  CHOL  eGFR  
Yes RBS Age CHOL  Non-HDL  BMI eGFR 
MLP (SHAP 
& LIME) 
No RBS Age Non-HDL  CHOL BMI eGFR 
Yes RBS  Age  eGFR  CHOL  Non-HDL  BMI   
 
Table 4 and the figures in Multimedia Appendix 6 show that all of the models are heavily 
and interchangeably reliant on Age and RBS when making classification decisions. The 
RF and SVM models, when trained with longitudinal data, ranks RBS over Age.   Figures 
6 and 7 highlight the importance our best performing model, MLP, places upon the 
features in our dataset using SHAP and LIME, respectively. Both figures show that the 
RBS contributes the most to the MLP’s final prediction, whilst the patient’s BMI 
contributes the least. 
 
For all models trained with longitudinal data, BMI is ranked lower than when the models 
are trained without longitudinal data. However, the importance value produced for the 
BMI variable from the models is still not insignificant (see Figures in Multimedia 
Appendix 7). This indicates that models are able to find subtle relationships in the 






Figure 6. Relative importance of predictors obtained from MLP trained with longitudinal 




Figure 7. Relative importance of predictors obtained from MLP trained with longitudinal 
data using LIME. 
 
 
When using the MLP and LR models trained on the longitudinal data the eGFR variable 
is ranked higher than CHOL and BMI, in contrast to when these are trained on the current 
visit only.  None of the other models trained with the current visit only, except RF, 
consider it important. Again, we ascribe this to the information that the model learns from 
the variations of eGFR values between a patient’s visits (longitudinal EHR data).  
 
SHAP values are calculated on the sample level. Figures 8 and 9 illustrate the SHAP 
values for 2 randomly selected sample patients from our dataset. These figures highlight 
how different inputs have different SHAP values. The patient in Figure 8 (for whom our 
model correctly predicts elevated HbA1c levels (≥5.7%)) has a higher RBS value than 
the patient in Figure 9 (for whom our model correctly predicts normal HbA1c levels 
(<5.7%)). This explains why our MLP model places much more importance on the RBS 
value of the patient in Figure 6. 
 
 
Figure 8. An example shows the SHAP values for a randomly selected sample patient 
with elevated HbA1c levels (≥5.7%). 
 
 
Figure 9. An example shows the SHAP values for a randomly selected sample patient 




The task of predicting HbA1c elevation risk can be challenging. Figure 10 provides a 
visualization of the datapoints for the 2 classes (pre-diabetic with ≥5.7%) and (normal 
with <5.7%) after mapping the datapoints (for the test data) into 2 dimensions using t-
SNE [50]. The overlap in the datapoints visualized in the figure demonstrates the 
challenge of separating the patients with and without elevated levels of HbA1c (≥5.7%) 
in the KAIMRC dataset. We avoided intensive feature engineering techniques in the 
sampling approach used. However, the approaches adopted are able to achieve promising 








In summary, all models show promising results for predicting the current HbA1c 
elevation levels (≥5.7%) using EHR data. The results emphasize that the HbA1c 
predictive models can exhibit more learnability when they are trained with the patient 
longitudinal observations that are normally available from EHR systems. 
 
Discussion and conclusion 
 
 
EHR systems were adopted for the purpose of improving healthcare outcomes and were 
not originally intended for research purposes [19]. Patient data stored in EHR systems 
can be obtained at irregular intervals, as lab instructions are carried out with different 
frequencies based on the physician's decisions and a patient’s visit patterns. It is very 
common that medical data extracted from EHR systems suffer from problems such as 
irregularity, incompleteness, and noisy and imbalanced data [13]. These can be 
challenging obstacles for any technology used for predictive analytics. 
 
The sampling approach used did not affect the balanced nature of the dataset used. As 
shown in Figure 2, there were 56,185 unique patients before removing the records with 1 
or more missing values. The number of unique patients with elevated HbA1c levels 
(≥5.7) before removing the incomplete records was 27,354 with 48.68% 
(27,354/56,185). The number of unique patients with normal HbA1c levels was 28,831 
with 51.32% (28,831/56,185). We would argue that the absence or the presence of the 
HbA1c readings is not random. Being a sample collected from the population of Saudi 
Arabia, the likelihood of a patient taking an HbA1c test is large because of the prevalence 
of diabetes [51]. This may affect the reproducibility of this work using different 
populations from different countries especially those with lower rates of diabetes. 
 
It is hoped that these outcomes will encourage further investigation into the predictability 
of current HbA1c levels (≥5.7%) using more of the readings normally provided in EHR 
data. For example, other important readings such as FBS and triglycerides have shown 
clinical correlations with diabetes [52]. In addition, our dataset contained only 3 years of 
patient data, which limits the number of patient visits recorded. Figure 11 shows the 
number of visits made by patients from 2016 to 2018. Figure 12 details the number of 
visits made by patients (after removing the outliers) over HbA1c levels. Both figures 
show that the majority of the patients have made relatively few visits. 52% (8713/ 16818) 
of the patients have made 4 visits or fewer during the 3 years (1.3 visit per year). This 
also justifies the size of the sliding window (𝑠 = 3) as the optimal input size for the 
models employed. However, we hypothesize that the longitudinal behavior of the features 
used can be enriched by employing more values obtained over longer periods. Therefore, 
incorporating more features and their longitudinal behavior over longer periods into the 
models used in this study would be likely to improve the prediction performance of our 
chosen models. 
 
Figure 11. Histogram showing the trend in the number of visits made by patients. 
 
 




Variations in the data/model produce slightly different attribution values. However, due 
to the critical nature of many healthcare applications, it is always important to verify that 
our models make ‘sensible’ predictions. Without the use of SHAP/LIME, this would be 
hard to verify for any non-linear model. Although it is possible to see that the models 
have high performance, we would be unable to verify that a model is not making spurious 
correlations. Furthermore, through the use of SHAP, we can verify that MLPs trained on 
the longitudinal data are learning to use the extra information contained in the 
longitudinal data (as indicated by the higher importance of eGFR), allowing us to 
pinpoint the reason these models gain higher performance. 
 
To investigate the effect of temporal dependencies in the data, this study has involved 
investigating the use of other deep learning models along with the MLP, such as Long-
Short Term Memory (LSTM) and Bidirectional LSTM [25, 53] for HbA1c prediction. 
Table 5 reports the results of using these models. The MLP model achieved similar 
performance to the LSTM and BiLSTM models using all reported measures. This 
suggests that directly modelling the temporal dynamics in the data is not very helpful. 
This could be due to the short lengths of the time series, or to weak temporal dependency. 
 
















LSTMa Yes 83.26% (0.91) 74.17% (1.05) 74.59% (1.23) 75.64% (1.50) 74.59% (3.26) 81.88% (0.95) 
BiLSTMb Yes 83.16% (0.87) 74.21% (1.24) 74.30% (1.15) 75.46% (1.39) 75.19% (2.36) 84.75% (0.75) 
aLSTM: Long-Short Term Memory. 
bBiLSTM: Bidirectional LSTM. 
 
Generalizing our findings using other datasets is challenging because of the accessibility 
and privacy restrictions that apply to medical datasets. For this reason, and because of the 
lack of similar studies that have employed machine learning for HbA1c prediction using 
EHR data, comparing the performance achieved by the models outlined in this work with 





We believe that this study is the first to investigate the performance of machine learning 
models used with EHR data for predicting current HbA1c elevation risk (≥5.7%) for 
non-diabetic patients. It is also the first to investigate employing the longitudinal data that 
are normally stored on EHR systems to enhance the prediction of HbA1c elevation levels.  
Our findings show that the MLP model achieves better results when a patient’s 
longitudinal data are combined with current visit data, and the use of longitudinal data 
also affects the relative importance for the predictors used. 
 
As this work formed a continuation of previous work [24], we avoided changing the 
sampling approach used. However, studying the impact of applying different sampling 
approaches could be valuable to explore in future work, as would the use of a larger 
dataset with more variables and the recording of longitudinal behavior over longer 
periods. 
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